行为疗法加氟桂利嗪预防性治疗儿童偏头痛效果观察

陈言钊; 李宁; 周克英

doi:10.7499/j.issn.1008-8830.2014.11.006

PDF(1177 KB)

中国当代儿科杂志 ›› 2014, Vol. 16 ›› Issue (11) : 1105-1108. DOI: 10.7499/j.issn.1008-8830.2014.11.006

论著·临床研究

行为疗法加氟桂利嗪预防性治疗儿童偏头痛效果观察

陈言钊¹, 李宁², 周克英¹

作者信息 +

Preventive effect of behavioral therapy plus flunarizine in children with migraine

CHEN Yan-Zhao¹, LI Ning², ZHOU Ke-Ying¹

Author information +

文章历史 +

摘要

目的探讨行为疗法加氟桂利嗪预防性治疗儿童偏头痛的临床效果.方法 2011 年1 月至2014 年1 月就诊的90 名偏头痛患儿随机分为治疗组(45 例)和对照组(45 例),对照组接受口服氟桂利嗪治疗,治疗组采用行为疗法同时口服氟桂利嗪,应用儿童偏头痛残疾程度评分(PedMIDAS)及改良Bussone 头痛指数连续3 个月观察治疗效果.结果治疗前两组间PedMIDAS 值差异无统计学意义(P>0.05),治疗后3 个月治疗组PedMIDAS 值显著低于对照组(16±8 vs 20±10,P<0.05).治疗前两组间改良Bussone 头痛指数值差异无统计学意义(P>0.05),治疗后3 个月治疗组改良Bussone 头痛指数值显著低于对照组(25±18 vs 37±21,P<0.05).结论行为疗法加氟桂利嗪预防性治疗儿童偏头痛较单用氟桂利嗪有更好的效果,可考虑临床推广应用.

Abstract

Objective To investigate the preventive effect of behavioral therapy plus flunarizine in children withmigraine. Methods Ninety pediatric patients with migraine between January 2011and January 2014 were randomlydivided into treatment group (45 cases) and control group (45 cases). The treatment group received behavioral therapy in addition to oral flunarizine, while the control group received oral flunarizine alone. All patients were followed upfor 3 months to evaluate the therapeutic effect by the Pediatric Migraine Disability Assessment Score (PedMIDAS)and improved Bussone headache index. Results There were no significant differences in Ped MIDAS (P>0.05) andimproved Bussone headache index (P>0.05) between the control and treatment groups before treatment. Significantdifferences were observed in PedMIDAS (16±8 vs 20±10; P<0.05) and improved Bussone headache index (25±18 vs37±21; P<0.05) between the two groups after 3 months of treatment. Conclusions Preventive treatment of behavioraltherapy plus oral flunarizine shows a better clinical efficacy than oral flunarizine alone in children with migraine andholds promise for clinical application.

导出引用

陈言钊, 李宁, 周克英. 行为疗法加氟桂利嗪预防性治疗儿童偏头痛效果观察[J]. 中国当代儿科杂志. 2014, 16(11): 1105-1108 https://doi.org/10.7499/j.issn.1008-8830.2014.11.006

CHEN Yan-Zhao, LI Ning, ZHOU Ke-Ying. Preventive effect of behavioral therapy plus flunarizine in children with migraine[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(11): 1105-1108 https://doi.org/10.7499/j.issn.1008-8830.2014.11.006

参考文献

[1] Lewis D, Ashwal S, Hershey A, et al. Practice parameter:pharmacological treatment of migraine headache in children and adolescents:report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society[J]. Neurology, 2004, 63(12):2215-2224.
[2] Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents a randomized clinical trial[J]. JAMA, 2013, 310(24):2622-2630.
[3] Estemalik E, Tepper S. Preventive treatment in migraine and the new US guidelines[J]. Neuropsychiatr Dis Treat, 2013, 9:709-720.
[4] 周克英, 文飞球, 王玉珍, 等. 发作间期脑血流动力学改变对偏头痛预防性治疗效果的影响[J]. 中国当代儿科杂志, 2004, 6(3):207-210.
[5] Connelly M. Cognitive behavioral therapy for treatment of pediatric chronic migraine[J]. JAMA, 2013, 310(24):2617-2618.
[6] Shapiro RE. Preventive treatment of migraine[J]. Headache, 2012, 52(Suppl 2N):65-69.
[7] Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed[J]. Cephalalgia, 2004, 24(Suppl 1):9-160.
[8] Hershey AD, Powers SW, Vockell AL, et al. PedMIDAS:Development of a questionnaire to assess disability of migraines in children[J]. Neurology, 2001, 57(11):2034-2039.
[9] Bussone G, Baldini S, Andrea DG, et al. Nimodipine versus flunarizine in common migraine:a controlled pilot trial[J]. Headache, 1987, 27(2):76-79.
[10] Silberstein SD. Preventive migraine treatment[J]. Neurol Clin, 2009, 27(2):429-443.
[11] Rizzoli PB. Acute and preventive treatment of migraine[J]. Continuum (Minneap Minn), 2012, 18(4):764-782.
[12] Antonaci F, Nappi G, Galli F, et al. Migraine and psychiatric comorbidity:a review of clinical findings[J]. J Headache Pain, 2011, 12(2):115-125.
[13] 张海菊, 王玉玮, 孙若鹏, 等. 偏头痛患儿的心理行为特征研究[J]. 中国儿童保健杂志, 2007, 15(4):357-359.
[14] Baskin SM, Smitherman TA. Migraine and psychiatric disorders:comorbidities,mechanisms, and clinical applications[J]. Neurol Sci, 2009, 30(1 Suppl):61-65.
[15] Seng EK, Holroyd KA. Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial[J]. Cephalalgia, 2012, 32(5):390-400.
[16] Buse DC, Andrasik F. Behavioral medicine for migraine[J]. Neurol Clin, 2009, 27(2):445-465.
[17] Rains JC, Penzien DB. Behavioral treatment strategies for migraine and tension-type headache:a review of the evidence and future directions[J]. Expert Rev Neurother, 2002, 2(5):749-760.
[18] Pistoia F, Sacco S, Carolei A. Behavioral therapy for chronic migraine[J]. Curr Pain Headache Rep, 2013, 17(1):304.
[19] Voerman JS, Klerk CD, Merelle SY, et al. Long-term followup of home-based behavioral management training provided by migraine patients[J]. Cephalalgia, 2014, 34(5):357-364.
[20] Hedborg K, Muhr C. The influence of multimodal behavioral treatment on the consumption of acute migraine drugs:a randomized, controlled study[J]. Cephalalgia, 2012, 32(4):297-307.
[21] Hedborg K, Muhr C. Multimodal behavioral treatment of migraine:an internet-administered, randomized, controlled trial[J]. Ups J Med Sci, 2011, 116(3):169-186.
[22] Cottrell C, Drew J, Gibson J, et al. Feasibility assessment of telephone-administered behavioral treatment for adolescent migraine[J]. Headache, 2007, 47(9):1293-1302.